Inhibition of morphine analgesia by lithium: Role of peripheral and central opioid receptors

Behavioural Brain Research

Volumn 151, Issue 1-2, 2004, Pages 151-158

  Johnston, Ian N ^a   Westbrook, R Frederick ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Analgesic tolerance; Anti analgesia; Lithium chloride; Morphine; Naloxone; Opioid receptor

Indexed keywords

17 METHYLNALOXONE; LITHIUM CHLORIDE; MORPHINE; NALOXONE; OPIATE RECEPTOR;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; INJECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALGESIA; ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; ANTIMANIC AGENTS; DRUG ADMINISTRATION ROUTES; DRUG INTERACTIONS; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; LITHIUM CHLORIDE; MALE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; PAIN MEASUREMENT; PAIN THRESHOLD; RATS; RATS, WISTAR; RECEPTORS, OPIOID; TIME FACTORS;

EID: 16544392967     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2003.08.022     Document Type: Article

References (72)

1. Bechara A., van der Kooy D. Opposite motivational effects of endogenous opioids in brain and periphery. Nature. 314:1985;533-534.
2. Beyaert R., Schulze-Osthoff K., Van Roy F., Fiers W. Lithium chloride potentiates tumor necrosis factor-induced and interleukin 1-induced cytokine and cytokine receptor expression. Cytokine. 3:1991;284-291.
3. Blatteis C.M., Xin L., Quan N. Neuromodulation of fever: apparent involvement of opioids. Brain Res. Bull. 26:1991;219-223.
4. Bolles R.C., Fanselow M.S. A perceptual-defensive-recuperative model of fear and pain. Behav. Brain Sci. 3:1980;291-323.
5. Borgland S.L. Acute opioid receptor desensitization and tolerance: is there a link? Clin. Exp. Pharmacol. Physiol. 28:2001;147-154.
6. Burns G., Herz A., Nikolarakis K.E. Stimulation of hypothalamic opioid peptide release by lithium is mediated by opioid autoreceptors: evidence from a combined in vitro, ex vivo study. Neuroscience. 36:1990;691-697.
7. Celerier E., Laulin J.P., Corcuff J.B., Le Moal M., Simonnet G. Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: a sensitization process. J. Neurosci. 21:2001;4074-4080.
8. Chang R.C., Rota C., Glover R.E., Mason R.P., Hong J.S. A novel effect of an opioid receptor antagonist, naloxone, on the production of reactive oxygen species by microglia: a study by electron paramagnetic resonance spectroscopy. Brain Res. 854:2000;224-229.
9. Crain S.M., Shen K.F. Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons. Trends Pharmacol. Sci. 11:1990;77-81.
10. Crain S.M., Shen K.F. Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment. Proc. Natl. Acad. Sci. USA. 92:1995;10540-10544.
11. Crain S.M., Shen K.F. Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia. Brain Res. 888:2001;75-82.
12. Crain S.M., Shen K.F., Chalazonitis A. Opioids excite rather than inhibit sensory neurons after chronic opioid exposure of spinal cord-ganglion cultures. Brain Res. 455:1988;99-109.
13. Das K.P., McMillian M.K., Bing G., Hong J.S. Modulatory effects of [Met5]-enkephalin on interleukin-1 beta secretion from microglia in mixed brain cell cultures. J. Neuroimmunol. 62:1995;9-17.
14. Dashwood M.R., Muddle J.R., Spyer K.M. Opiate receptor subtypes in the nucleus tractus solitarii of the cat: the effect of vagal section. Bur. J. Pharmacol. 155:1988;85-92.
15. de Gandarias J.M., Acebes I., Echevarria E., Vegas L., Abecia L.C., Casis L. Lithium alters mu-opioid receptor expression in the rat brain. Neurosci. Lett. 279:2000;9-12.
16. Dehpour A.R., Farsam H., Azizabadi-Farahani M. The effect of lithium on morphine-induced analgesia in mice. Gen. Pharmacol. 25:1994;1635-1641.
17. Devillers J.P., Boisserie F., Laulin J.P., Larcher A., Simonnet G. Simultaneous activation of spinal antiopioid system (neuropeptide FF) and pain facilitatory circuitry by stimulation of opioid receptors in rats. Brain Res. 700:1995;173-181.
18. Fleming WW, Taylor DA. Cellular mechanisms of opioid tolerance and dependence. In: Tseng LF, editor. The Pharmacology of opioid peptides. Harwood Academic Publishers, GmBH; 1995. p. 463-502.
19. Fontela T., Garcia Hermida O., Gomez-Acebo J. Blocking effect of naloxone, dihydroergotamine and adrenalectomy in lithium-induced hyperglycaemia and glucose intolerance in the rat. Acta Endocrinol. 111:1986;342-348.
20. Foran S.E., Carr D.B., Lipkowski A.W., Maszczynska I., Marchand J.E., Misicka A.et al. Inhibition of morphine tolerance development by a substance P-opioid peptide chimera. J. Pharmacol. Exp. Ther. 295:2000;1142-1148.
21. Hart B.L. Biological basis of the behavior of sick animals. Neurosci. Biobehav. Rev. 12:1988;123-137.
22. Hawranko A.A., Serafini M., Smith D.J. Anti-analgesia and reduced antinociception from supraspinally administered beta-endorphin in stressed rats: dependence on spinal cholecystokinin via cholecystokinin B receptors. Neurosci. Lett. 267:1999;101-104.
23. Johnston I.N., Westbrook R.F. Acute and conditioned sickness reduces morphine analgesia. Behav. Brain Res. 142:2003;89-97.
24. Kent S., Bluthe R.M., Kelley K.W., Dantzer R. Sickhess behavior as a new target for drug development. Trends Pharmacol. Sci. 13:1992;24-28.
25. Kleinerman E.S., Knowles R.D., Blick M.B., Zwelling L.A. Lithium chloride stimulates human monocytes to secrete tumor necrosis factor/cachectin. J. Leukoc. Biol. 46:1989;484-492.
26. Kolesnikov Y.A., Pick C.G., Pastemak G.W. NG-nitro-L-arginine prevents morphine tolerance. Eur. J. Pharmacol. 221:1992;399-400.
27. Larson S.J., Dunn A.J. Behavioral effects of cytokines. Brain Behav. Immun. 15:2001;371-387.
28. Li X., Angst M.S., Clark J.D. A murine model of opioid-induced hyperalgesia. Brain Res. Mol. Brain Res. 86:2001;56-62.
29. Li X., Clark J.D. Hyperalgesia during opioid abstinence: mediation by glutamate and substance p. Anesth. Analg. 95:2002;979-984.
30. Lieblich I., Yirmiya R. Naltrexone reverses a long term depressive effect of a toxic lithium injection on saccharin preference. Physiol. Behav. 39:1987;547-550.
31. Lysle D.T., How T. Endogenous opioids regulate the expression of inducible nitric oxide synthase by splenocytes. J. Pharmacol. Exp. Ther. 288:1999;502-508.
32. Maier S.F., Watkins L.R. Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol. Rev. 105:1998;83-107.
33. Maier S.F., Wiertelak E.P., Martin D., Watkins L.R. Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin. Brain Res. 623:1993;321-324.
34. Mansour A., Fox C.A., Thompson R.C., Akil H., Watson S.J. Mu-opioid receptor mRNA expression in the rat CNS: comparison to mu-receptor binding. Brain Res. 643:1994;245-265.
35. Mao J., Price D.D., Mayer D.J. Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain. 61:1995;353-364.
36. McCarthy L., Wetzel M., Sliker J.K., Eisenstein T.K., Rogers T.J. Opioids, opioid receptors, and the immune response. Drug Alcohol. Depend. 62:2001;111-123.
37. McNally G.P. Pain facilitatory circuits in the mammalian central nervous system: their behavioral significance and role in morphine and analgesic tolerance. Neurosci. Biobehav. Rev. 23:1999;1059-1078.
38. McNally G.P., Johnston I.N., Westbrook R.F. A peripheral, intracerebral, or intrathecal administration of an opioid receptor antagonist blocks illness-induced hyperalgesia in the rat. Behav. Neurosci. 114:2000;1183-1190.
39. McNally G.P., Westbrook R.F. Effects of systemic, intracerebral, or intrathecal administration of an N-methyl-D-aspartate receptor antagonist on associative morphine analgesic tolerance and hyperalgesia in rats. Behav. Neurosci. 112:1998;966-978.
40. McNally G.P., Westbrook R.F. Test type influences the expression of lithium chloride-induced hyperalgesia. Pharmacol. Biochem. Behav. 61:1998;385-394.
41. McNally G.P., Westbrook R.F. Acute exposure to saccharin reduces morphine analgesia in the rat: evidence for involvement of N-methyl-D aspartate and peripheral opioid receptors. Psychopharmacologia. 149:2000;56-62.
42. Mellon R.D., Bayer B.M. Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity. Brain Res. 789:1998;56-67.
43. Mercadante S., Portenoy R.K. Opioid poorly-responsive cancer pain. Part 2: basic mechanisms that could shift dose response for analgesia. J. Pain Symptom Manage. 21:2001;255-264.
44. Nomura S., Ding Y.Q., Kaneko T., Li J.L., Mizuno N. Localization of mu-opioid receptor-like immunoreactivity in the central components of the vagus nerve: a light and electron microscope study in the rat. Neuroscience. 73:1996;277-286.
45. Nozaki-Taguchi N., Yaksh T.L. Spinal and peripheral mu opioids and the development of secondary tactile allodynia after thermal injury. Anesth. Analg. 94:2002;968-974.
46. Raffa R.B., Connelly C.D., Martinez R.P. Opioid efficacy is linked to the LiCl-sensitive, inositol-1,4,5-trisphosphate-restorable pathway. Eur. J. Pharmacol. 217:1992;221-223.
47. Raffa R.B., Martinez R.P. Morphine antinociception is mediated through a LiCl-sensitive, IP3-restorable pathway. Eur. J. Pharmacol. 215:1992;357-358.
48. Raffa R.B., Martinez R.P., Renzi M.J., Codd E.E. LiCl uncouples signal transduction in morphine-induced supraspinal antinociception in mice. Gen. Pharmacol. 26:1995;317-320.
49. Randich A., Gebhart G.F. Vagal afferent modulation of nociception. Brain Res. Brain Res. Rev. 17:1992;77-99.
50. Reisine TL, Pasternak GW. Opiate analgesics and antagonists. In: Hardman JG, Limbird RE, editors. Goodman and Gilman's pharmacological basis of therapeutics. New York: McGraw-Hill; 1995.
51. Rudy J.W., Kuwagama K., Pugh C.R. Isolation reduces contextual but not auditory-cue fear conditioning: a role for endogenous opioids. Behav. Neurosci. 113:1999;316-323.
52. Ruzicka B.B., Akil H. The interleukin-1beta-mediated regulation of proenkephalin and opioid receptor messenger RNA in primary astrocyte-enriched cultures. Neuroscience. 79:1997;517-524.
53. Ruzicka B.B., Thompson R.C., Watson S.J., Akil H. Interleukin-1 beta-mediated regulation of mu-opioid receptor mRNA in primary astrocyte-enriched cultures. J. Neurochem. 66:1996;425-428.
54. Sabol S.L., Yoshikawa K., Hong J.S. Regulation of methionine-enkephalin precursor messenger RNA in rat striatum by haloperidol and lithium. Biochem. Biophys. Res. Commun. 113:1983;391-399.
55. Shippenberg T.S., Millan M.J., Mucha R.F., Herz A. Involvement of beta-endorphin and mu-opioid receptors in mediating the aversive effect of lithium in the rat. Eur. J. Pharmacol. 154:1988;135-144.
56. Siegel S., Baptista M.A., Kim J.A., McDonald R.V., Weise-Kelly L. Pavlovian psychopharmacology: the associative basis of tolerance. Exp. Clin. Psychopharmacol. 8:2000;276-293.
57. Sivam S.P., Smith D.R., Takeuchi K., Hong J.S. Lithium and haloperidol differentially alter the dynorphin A (1-8) and enkephalin levels in the neurointermediate lobe of rat pituitary. Neuropeptides. 10:1987;291-298.
58. Sivam S.P., Strunk C., Smith D.R., Hong J.S. Proenkephalin-A gene regulation in the rat striatum: influence of lithium and haloperidol. Mol. Pharmacol. 30:1986;186-191.
59. Sivam S.P., Takeuchi K., Li S., Douglass J., Civelli O., Calvetta L.et al. Lithium increases dynorphin A(1-8) and prodynorphin mRNA levels in the basal ganglia of rats. Brain Res. 427:1988;155-163.
60. Staunton D.A., Deyo S.N., Shoemaker W.J., Ettenberg A., Bloom F.E. Effects of chronic lithium on enkephalin systems and pain responsiveness. Life Sci. 31:1982;1837-1840.
61. Takeda M., Tanimoto T., Ojima K., Matsumoto S. Suppressive effect of vagal afferents on the activity of the trigeminal spinal neurons related to the jaw-opening reflex in rats: involvement of the endogenous opioid system. Brain Res. Bull. 47:1998;49-56.
62. Trujillo K.A., Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science. 251:1991;85-87.
63. Van Koughnet K., Smirnova G., Hyman S.B., Borsook D. Proenkephalin transgene regulation in the paraventricular nucleus of the hypothalamus by lipopolysaccharide and interleukin-1beta. J. Comp. Neurol. 405:1999;199-215.
64. Vanderah T.W., Suenaga N.M., Ossipov M.H., Malan T.P. Jr., Lai J., Porreca F. Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J. Neurosci. 21:2001;279-286.
65. Watkins L.R., Goehler L.E., Relton J., Brewer M.T., Maier S.F. Mechanisms of tumor necrosis factor-alpha (TNF-alpha) hyperalgesia. Brain Res. 692:1995;244-250.
66. Watkins L.R., Wiertelak E.P., Furness L.E., Maier S.F. Illness-induced hyperalgesia is mediated by spinal neuropeptides and excitatory amino acids. Brain Res. 664:1994;17-24.
67. Watkins L.R., Wiertelak E.P., Goehler L.E., Mooney-Heiberger K., Martinez J., Furness L.et al. Neurocircuitry of illness-induced hyperalgesia. Brain Res. 639:1994;283-299.
68. Watkins L.R., Wiertelak E.P., Goehler L.E., Smith K.P., Martin D., Maier S.F. Characterization of cytokine-induced hyperalgesia. Brain Res. 654:1994;15-26.
69. Wiertelak E.P., Furness L.E., Watkins L.R., Maier S.F. Illness-induced hyperalgesia is mediated by a spinal NMDA-nitric oxide cascade. Brain Res. 664:1994;9-16.
70. Wiertelak E.P., Roemer B., Maier S.F., Watkins L.R. Comparison of the effects of nucleus tractus solitarius and ventral medial medulla lesions on illness-induced and subcutaneous formalin-induced hyperalgesias. Brain Res. 748:1997;143-150.
71. Wiertelak E.P., Smith K.P., Furness L., Mooney-Heiberger K., Mayr T., Maier S.F.et al. Acute and conditioned hyperalgesic responses to illness. Pain. 56:1994;227-234.
72. Yoshikawa K., Hong J.S. The enkephalin system in the rat anterior pituitary: regulation by gonadal steroid hormones and psychotropic drugs. Endocrinology. 113:1983;1218-1227.